GHK-Cu

Pickart (J. Cosmetic Dermatol.) reviews GHK-Cu's role in stimulating collagen, elastin, and glycosaminoglycan synthesis, improving skin density, thickness, and reducing fine lines.

Pickart et al. show GHK-Cu regulates expression of 4,000+ human genes, shifting patterns from diseased to healthy states applicable to COPD, cancer, and aging.

Comprehensive review demonstrating GHK-Cu accelerates wound closure, promotes angiogenesis, reduces scarring, and exhibits anti-inflammatory and antioxidant properties.

Study shows GHK-Cu increases collagen I and III gene expression, regulates metalloproteinases (MMP1, MMP2) and TIMP1, supporting balanced tissue remodeling.

Research demonstrates GHK-Cu provides UV photoprotection, reduces oxidative stress markers, and activates multiple regenerative and antioxidant genes in dermal cells.

A 2026 study demonstrated that the copper peptide GHK-Cu possesses laccase-like properties with excellent catalytic efficiency. Researchers found that this property enables GHK-Cu to be utilized in colorimetric sensors for the rapid detection of phenolic compounds like epinephrine and 2-aminophenol.

A 2026 review found that nine therapeutic peptides, including tirzepatide, epitalon, and BPC-157, target diverse aging hallmarks such as metabolic dysfunction and tissue repair. While FDA-approved agents demonstrated robust safety, investigational peptides require further clinical validation to establish long-term efficacy.

A 2026 study demonstrated that GHK-Cu decreased neutrophil and macrophage migration while suppressing pro-inflammatory cytokines in a zebrafish larvae model. The peptide also mitigated oxidative stress and downregulated the JAK1 pathway, highlighting its anti-inflammatory and antioxidant mechanisms.

A 2026 review found that while unapproved peptides like BPC-157 and TB-500 demonstrate favorable tissue repair in animal models, rigorous human safety data remain scarce. The researchers investigated the pharmacological mechanisms and regulatory status of these compounds in sports medicine.

Carbonless analogues of the GHK peptide demonstrated enhanced conformational plasticity and stronger copper binding stabilization compared to standard GHK, according to a 2026 computational study. These findings highlight the feasibility of using boron-nitrogen substitution to tune peptide behavior.